Gene · 80310
NIH grants1,097
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 1,097
Download this page as JSON| Grant | Title | PDGFD papers | Newest fiscal year |
|---|---|---|---|
| R01HL141326 | Role of an Integrator-EGR axis in the regulation of myeloid enhancers | 1 | 2023 |
| R01HL141853 | CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease | 1 | 2023 |
| R01HL146754 | International Consortium for Multimodality Phenotyping in Adults with Non-compaction | 1 | 2023 |
| R01HL147279 | Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial Infarction | 1 | 2023 |
| R01HL148167 | Understanding the Molecular Mechanisms of Fibromuscular Dysplasia | 1 | 2023 |
| R01HL148810 | Novel mechanisms of endothelial Injury in the pathogenesis of ARDS | 1 | 2023 |
| R01MH104610 | Transcriptional condensates, epigenetic editing and Rett Syndrome | 1 | 2023 |
| R01NS106170 | Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin | 1 | 2023 |
| R01NS120547 | Stinging the Glioma Immune Landscape | 1 | 2023 |
| R21AR078939 | Blastema-independent Mechanism for Regeneration in Salamanders | 1 | 2023 |
| R25GM061151 | Support for University Biomedical Excellence at UPR-RP | 1 | 2023 |
| R50CA243706 | Innovative approaches for the advancement of glioblastoma therapies | 1 | 2023 |
| SC1GM135050 | A novel metabolic reprograming strategy for the treatment of diabetes-associated breast cancer | 1 | 2023 |
| T32GM062754 | Integrated Training in Pharmacological Sciences | 1 | 2023 |
| U19AI110820 | A Genomics Based Investigation of the Determinants of Polymicrobial Infectious Disease Outcomes | 1 | 2023 |
| UM1CA186107 | Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study | 1 | 2023 |
| ZIAEY000320 | NEIBank: Est Analysis And Bioinformatics For Ocular Genomics | 1 | 2023 |
| R01DK096096 | CFTR modulates innate immune response in biliary epithelium: Role in the pathogenesis and treatment of Cystic-Fibrosis-related liver disease. | 2 | 2022 |
| R01HL113147 | Elucidation of Tissue-Specific Transcriptomic Profiles in Cardio-metabolic Disease | 2 | 2022 |
| R01HL148151 | The Impact of Oxidative Stress on Erythocyte Biology | 2 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/grants?page=15